Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-11-21

FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic glyburide and metformin hydrochloride combination from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLYBURIDE AND METFORMIN HYDROCHLORIDE (glyburide and metformin hydrochloride)

Snippet

SUPPL AP for GLYBURIDE AND METFORMIN HYDROCHLORIDE (GLYBURIDE AND METFORMIN HYDROCHLORIDE)